TNF and rheumatoid arthritis: Adalimumab, as a fully human monoclonal TNF inhibitor, has been widely used in the treatment of several immune-mediated inflammatory diseases including RA.[21] The patient underwent the treatment of hydroxychloroquine, iguratimod, and adalimumab, which obtained an ideal curative effect.